Works matching IS 0008543X AND DT 2016 AND VI 122 AND IP 3


Results: 27
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    13
    14
    15
    16
    17
    18
    19
    20
    22

    Risk factors and model for predicting toxicity-related treatment discontinuation in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor-targeted therapy: Results from the International Metastatic Renal Cell Carcinoma Database Consortium.

    Published in:
    2016
    By:
    • Kaymakcalan, Marina D.;
    • Xie, Wanling;
    • Albiges, Laurence;
    • North, Scott A.;
    • Kollmannsberger, Christian K.;
    • Smoragiewicz, Martin;
    • Kroeger, Nils;
    • Wells, J. Connor;
    • Rha, Sun‐Young;
    • Lee, Jae Lyun;
    • McKay, Rana R.;
    • Fay, André P.;
    • De Velasco, Guillermo;
    • Heng, Daniel Y. C.;
    • Choueiri, Toni K.
    Publication type:
    journal article
    23
    24

    Utilizing time-driven activity-based costing to understand the short- and long-term costs of treating localized, low-risk prostate cancer.

    Published in:
    2016
    By:
    • Laviana, Aaron A.;
    • Ilg, Annette M.;
    • Veruttipong, Darlene;
    • Tan, Hung‐Jui;
    • Burke, Michael A.;
    • Niedzwiecki, Douglas R.;
    • Kupelian, Patrick A.;
    • King, Chris R.;
    • Steinberg, Michael L.;
    • Kundavaram, Chandan R.;
    • Kamrava, Mitchell;
    • Kaplan, Alan L.;
    • Moriarity, Andrew K.;
    • Hsu, William;
    • Margolis, Daniel J. A.;
    • Hu, Jim C.;
    • Saigal, Christopher S.
    Publication type:
    journal article
    25
    26
    27